Quick answer
Eli Lilly's direct-to-patient pharmacy and telehealth platform launched in 2024, offering cash-pay Zepbound vials at lower prices than brand pen pricing.
Full definition
LillyDirect is Eli Lilly's direct-to-consumer platform offering Zepbound, Mounjaro, and other Lilly medications. It includes a telehealth pathway via independent providers, direct pharmacy dispensing, and the 'Zepbound vial program' launched in 2024 — single-dose vials at lower prices for self-pay patients (starting around $349/month for 2.5 mg and scaling with dose). LillyDirect explicitly does not accept insurance for the vial program, which is positioned as a competitor to compounded tirzepatide.
Deep dive
LillyDirect: complete reference
LillyDirect is Eli Lilly's direct-to-consumer cash-pay program selling Zepbound single-dose vials at fixed prices regardless of insurance status. Pricing tiers as of 2026: $349/month (2.5mg starter vial) up to $499/month (15mg maintenance vial). LillyDirect is one of the most disruptive pricing programs in the GLP-1 space — it offers FDA-approved tirzepatide (Zepbound) at substantially below the $1,086 list price, accessible to anyone in the US with a valid prescription, no insurance billing required. Limitations: cash-pay only (does not bill insurance), single-dose vials requiring self-injection from vial (not autoinjector pen — slightly more dexterity required), shipping logistics через partner pharmacy. For Mounjaro (the diabetes indication equivalent), there is no comparable LillyDirect program. LillyDirect has materially shifted the cost equation для cash-pay GLP-1 patients — making FDA-approved Zepbound competitive с compounded semaglutide pricing for many users.
- In practice
- You want Zepbound but your insurance doesn't cover it. Through LillyDirect, you pay $349-499/month direct to Lilly + their partner pharmacy — significantly cheaper than $1,086 list price.
- Clinical context
- LillyDirect is the cheapest FDA-approved tirzepatide path в 2026. Compare carefully с compounded semaglutide cost.
Medications
LillyDirect is most directly relevant to the following GLP-1 medications:
Related terms
- NovoCare — Novo Nordisk's patient support program that includes savings cards, copay assistance, and direct-pay…
- Manufacturer Savings Card — A coupon or copay card provided by drug manufacturers to reduce out-of-pocket cost for commercially …
- Single-Dose Vial — A small glass container holding one dose of medication, typically drawn into a syringe by the patien…
Continue learning
GLP1Zoom glossary is educational reference. Definitions are summary interpretations of clinical sources and not a substitute for prescribing-information detail. Full disclaimer.
References
Glucagon-Like Peptide-1 Receptor Agonists: Mechanisms и Clinical Use (Drucker, Cell Metabolism)(2018)
Tirzepatide GIP/GLP-1 Dual Agonism: Mechanism Review (Lancet Diabetes & Endocrinology)(2021)
GLP-1 Effects on Gastric Emptying: Pharmacology Review (American J Physiology)(2020)
Endocrine Society Clinical Practice Guideline: Pharmacological Management of Obesity(2015)
STEP-1 trial: Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding et al., NEJM)(2021)
SURMOUNT-1 trial: Tirzepatide Once Weekly для Treatment of Obesity (Jastreboff et al., NEJM)(2022)
SUSTAIN-6 trial: Semaglutide and Cardiovascular Outcomes (Marso et al., NEJM)(2016)
SURPASS-2 trial: Tirzepatide vs Semaglutide в Type 2 Diabetes (Frias et al., NEJM)(2021)
LEADER trial: Liraglutide and Cardiovascular Outcomes в T2D (Marso et al., NEJM)(2016)